1. Stocks
  2. Mereo Biopharma Group Plc - ADR
  3. Swot
swot-logo

Mereo Biopharma Group Plc - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Mereo Biopharma Group Plc - ADR has 5 Strengths, 17 Weaknesses, 6 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

PEG lower than Industry PEG

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Stock with Low PE (PE < = 10)

Stocks with Quarter Change % less than Industry

New 52 week low today

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Near 52 Week Low

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months